(Q35749244)

10 August 2017

title

Advanced glycation end products and receptor for advanced glycation end products in AA amyloidosis (English)

1 reference

10 August 2017

Christoph Röcken

1

1 reference

10 August 2017

Rosemarie Kientsch-Engel

2

1 reference

10 August 2017

Sophie Mansfeld

3

1 reference

10 August 2017

Barbara Stix

4

1 reference

10 August 2017

Kay Stubenrauch

5

1 reference

10 August 2017

Bernd Weigle

6

1 reference

10 August 2017

Frank Bühling

7

1 reference

10 August 2017

Mona Schwan

8

1 reference

10 August 2017

Wolfgang Saeger

9

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

The American Journal of Pathology

10 August 2017

published in

1 reference

10 August 2017

volume

162

1 reference

10 August 2017

issue

4

1 reference

10 August 2017

page(s)

1213-1220

1 reference

Pathology, diagnosis and pathogenesis of AA amyloidosis

10 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851237

N -Glycans on the receptor for advanced glycation end products influence amphoterin binding and neurite outgrowth

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851237

Proteolysis of AA amyloid fibril proteins by matrix metalloproteinases-1, -2, and -3.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851237

Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851237

Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851237

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851237

A putative role for cathepsin K in degradation of AA and AL amyloidosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851237

Inflammation and advanced glycation end products in uremia: simple coexistence, potentiation or causal relationship?

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851237

The biology of the receptor for advanced glycation end products and its ligands

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851237

Advanced glycation and lipoxidation end products: role of reactive carbonyl compounds generated during carbohydrate and lipid metabolism.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851237

Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851237

N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851237

Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851237

Diagnosis and immunohistochemical classification of systemic amyloidoses. Report of 43 cases in an unselected autopsy series

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851237

Advanced glycation end-products and atherosclerosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851237

beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851237

Serum amyloid A protein and C-reactive protein levels in pulmonary tuberculosis: relationship to amyloidosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851237

Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt-Jakob disease with prion plaques.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851237

Advanced glycation end products in children with chronic renal failure and type 1 diabetes

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851237

Distribution pattern of matrix metalloproteinases 1, 2, 3, and 9, tissue inhibitors of matrix metalloproteinases 1 and 2, and alpha 2-macroglobulin in cases of generalized AA- and AL amyloidosis.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851237

An evaluation of antigen retrieval procedures for immunoelectron microscopic classification of amyloid deposits.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1851237

Recent progress in advanced glycation end products and diabetic complications

25 September 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963917-X

Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963917-X

Alzheimer's disease--synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963917-X

Immunohistochemical study with anti-advanced glycation end-products antibody in murine amyloidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963917-X

Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963917-X

Relationship between pentosidine levels in serum and urine and activity in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963917-X

Rosai-Dorfman disease and generalized AA amyloidosis: a case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963917-X

The classification of amyloid deposits in clinicopathological practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963917-X

Formation of plasma advanced glycosylation end products (AGEs) has no influence on plasma viscosity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963917-X

Amyloid beta 2-microglobulin is modified with imidazolone, a novel advanced glycation end product, in dialysis-related amyloidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963917-X

Glycoxidative modification of AA amyloid deposits in renal tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963917-X

Advanced glycation end products: detection and reversal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963917-X

Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor kB (NF-kB) activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963917-X

Potential value of CML-Hb in predicting the progression of bone cysts in dialysis-related amyloidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963917-X

Cd36, a member of the class b scavenger receptor family, as a receptor for advanced glycation end products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963917-X

Increased concentrations of serum pentosidine in rheumatoid arthritis

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/12651613

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/S0002-9440(10)63917-X

1 reference

10 August 2017

1 reference

10 August 2017

1 reference